Canaccord lowered the firm’s price target on HealthStream (HSTM) to $28 from $29 and keeps a Hold rating on the shares. The firm said they reported a solid bounce back quarter following a disappointing 1Q report in back in May. Four of the five delayed deals cited last quarter crossed the finish line in 2Q, with the fifth expected to be closed in 3Q. Notably, the average total contract size of $2.2 million was highlighted as these were previously characterized as medium-sized deals.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSTM:
